Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
- PMID: 25711488
- PMCID: PMC5008168
- DOI: 10.1111/bju.13101
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
Abstract
Objectives: To improve awareness and recognition of chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non-specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP/CPPS, in both non-specialist and specialist settings. To promote efficient referral of care between non-specialists and specialists and the involvement of the multidisciplinary team (MDT).
Patients and methods: The guideline population were men with CBP or CP/CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP/CPPS (published between 1999 and February 2014). A Delphi panel process was used where high-quality, published evidence was lacking.
Results: CBP and CP/CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms (LUTS - voiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first-line treatment include antibiotics, α-adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle.
Conclusion: Chronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom-based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP/CPPS.
Keywords: chronic bacterial prostatitis; chronic prostatitis with chronic pelvic pain syndrome; guidelines; prostatitis.
© 2015 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
Figures

Comment in
-
Chronic prostatitis: how to give our best without apposite vagueness.BJU Int. 2015 Oct;116(4):499-500. doi: 10.1111/bju.13150. BJU Int. 2015. PMID: 26350575 No abstract available.
Similar articles
-
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.Eur Urol. 2016 Feb;69(2):286-97. doi: 10.1016/j.eururo.2015.08.061. Epub 2015 Sep 26. Eur Urol. 2016. PMID: 26411805 Review.
-
Common Questions About Chronic Prostatitis.Am Fam Physician. 2016 Feb 15;93(4):290-6. Am Fam Physician. 2016. PMID: 26926816 Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review.BJU Int. 2019 Aug;124(2):197-208. doi: 10.1111/bju.14492. Epub 2019 Jan 17. BJU Int. 2019. PMID: 30019814
-
Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.Expert Opin Pharmacother. 2010 Jun;11(8):1255-61. doi: 10.1517/14656561003709748. Expert Opin Pharmacother. 2010. PMID: 20429665 Review.
-
A review of current treatments for chronic prostatitis/chronic pelvic pain syndrome under the UPOINTS system.Int J Urol. 2023 May;30(5):431-436. doi: 10.1111/iju.15149. Epub 2023 Feb 14. Int J Urol. 2023. PMID: 36788717 Review.
Cited by
-
The methodological quality assessment of systematic reviews/meta-analyses of chronic prostatitis/chronic pelvic pain syndrome using AMSTAR2.BMC Med Res Methodol. 2023 Nov 27;23(1):281. doi: 10.1186/s12874-023-02095-0. BMC Med Res Methodol. 2023. PMID: 38012566 Free PMC article.
-
A systematic review of cross-cultural adaptation of the National Institutes of Health Chronic Prostatitis Symptom Index.Health Qual Life Outcomes. 2021 May 31;19(1):159. doi: 10.1186/s12955-021-01796-8. Health Qual Life Outcomes. 2021. PMID: 34059073 Free PMC article.
-
[Microbial etiology of bacterial chronic prostatitis: systematic review].Rev Esp Quimioter. 2023 Apr;36(2):144-151. doi: 10.37201/req/099.2022. Epub 2023 Jan 9. Rev Esp Quimioter. 2023. PMID: 36622055 Free PMC article. Spanish.
-
Male CP/CPPS: where do we stand?World J Urol. 2019 Jun;37(6):1015-1022. doi: 10.1007/s00345-019-02718-6. Epub 2019 Mar 12. World J Urol. 2019. PMID: 30864007 Review.
-
Comparing the effectiveness of extracorporeal shockwave therapy and myofascial release therapy in chronic pelvic pain syndrome: study protocol for a randomized controlled trial.Trials. 2023 Oct 18;24(1):675. doi: 10.1186/s13063-023-07633-1. Trials. 2023. PMID: 37853420 Free PMC article.
References
-
- Pavone‐Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU‐EBU Update Ser 2007; 5: 1–15
-
- Nyberg LM, Krieger JN, Nickel JC. National Institutes of Health Classification of Chronic Prostatitis In Nickel JC. ed, Textbook of Prostatitis. London: CRC Press, 1999: 28
-
- University of Oxford Centre for Evidence Based Medicine . OCEBM Levels of Evidence System. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed June 2014
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous